Background Mechanical stress on the heart is commonly considered the sole stimulus explaining the synthesis and release of ...
4d
Pharmaceutical Technology on MSNUSPTO allows patents for Remedy’s large hemispheric infarction drugThe US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara to treat large ...
T lymphocytes that collect at infarction zones within 24 h of a stroke have been suggested to have an important role in the progression of cerebral ischemia–reperfusion (I–R) injury.
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
and increases cerebral infarct size (Alvarez-Sabín et al., 2003). In a study of 63 patients with sudden-onset focal neurological deficit consistent with hemispherical ischemic stroke who received ...
TNKase was initially approved in 2000 to reduce the risk of death from acute ST-elevation myocardial infarction (STEMI ... clot blocks blood flow to the brain, leading to brain damage, disability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results